LBX Pharmacy Chain JSC
SSE:603883
Net Margin
LBX Pharmacy Chain JSC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | CN |
Market Cap | 20.9B CNY |
Net Margin |
4%
|
Country | ZA |
Market Cap | 74.7B Zac |
Net Margin |
6%
|
Country | ZA |
Market Cap | 28.6B Zac |
Net Margin |
3%
|
Country | US |
Market Cap | 15.6B USD |
Net Margin |
-4%
|
Country | BR |
Market Cap | 45.5B BRL |
Net Margin |
3%
|
Country | CN |
Market Cap | 46.6B CNY |
Net Margin |
6%
|
Country | JP |
Market Cap | 945B JPY |
Net Margin |
5%
|
Country | SA |
Market Cap | 17.4B SAR |
Net Margin |
10%
|
Country | MX |
Market Cap | 77.3B MXN |
Net Margin |
4%
|
Country | JP |
Market Cap | 545.1B JPY |
Net Margin |
3%
|
Country | CN |
Market Cap | 25.3B CNY |
Net Margin |
5%
|
Profitability Report
View the profitability report to see the full profitability analysis for LBX Pharmacy Chain JSC.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on LBX Pharmacy Chain JSC's most recent financial statements, the company has Net Margin of 4.3%.